(Reuters) - India's drugs regulator gave final approval on Sunday for the emergency-use of a COVID-19 vaccine developed by AstraZeneca and Oxford University. Britain, El Salvador and Argentina have also approved the vaccine.
Once front-runners in a global race to develop a vaccine, the AstraZeneca and University of Oxford partnership has been overtaken by Pfizer and German partner BioNTech, whose vaccine is already being used in Britain and the United States.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!